Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

The Comparative Diagnostic Features of Canine and Human Lymphoma.

Seelig DM, Avery AC, Ehrhart EJ, Linden MA.

Vet Sci. 2016 Jun;3(2). pii: 11. doi: 10.3390/vetsci3020011. Epub 2016 Jun 9.

2.

Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.

Xie S, Shen C, Tan M, Li M, Song X, Wang C.

Oncotarget. 2017 Apr 18;8(16):27216-27239. doi: 10.18632/oncotarget.16111.

3.

Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases.

Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E.

Oncol Ther. 2016;4(2):199-210. doi: 10.1007/s40487-016-0026-y. Epub 2016 Aug 18.

4.

Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).

Perucca S, Di Palma A, Piccaluga PP, Gemelli C, Zoratti E, Bassi G, Giacopuzzi E, Lojacono A, Borsani G, Tagliafico E, Scupoli MT, Bernardi S, Zanaglio C, Cattina F, Cancelli V, Malagola M, Krampera M, Marini M, Almici C, Ferrari S, Russo D.

PLoS One. 2017 Feb 23;12(2):e0172430. doi: 10.1371/journal.pone.0172430. eCollection 2017.

5.

Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.

Wang CY, Shahi P, Huang JT, Phan NN, Sun Z, Lin YC, Lai MD, Werb Z.

Mol Clin Oncol. 2017 Jan;6(1):7-18. doi: 10.3892/mco.2016.1094. Epub 2016 Nov 25.

6.

Confident gene activity prediction based on single histone modification H2BK5ac in human cell lines.

Chitsazian F, Sadeghi M, Elahi E.

BMC Bioinformatics. 2017 Jan 25;18(1):67. doi: 10.1186/s12859-016-1418-6.

7.

A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance.

Dimberg LY, Towers CG, Behbakht K, Hotz TJ, Kim J, Fosmire S, Porter CC, Tan AC, Thorburn A, Ford HL.

Mol Cancer Res. 2017 Apr;15(4):382-394. doi: 10.1158/1541-7786.MCR-16-0234. Epub 2017 Jan 20.

PMID:
28108622
8.

The heterogeneous landscape of ALK negative ALCL.

Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R.

Oncotarget. 2017 Mar 14;8(11):18525-18536. doi: 10.18632/oncotarget.14503. Review.

9.

Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.

van Andel H, Ren Z, Koopmans I, Joosten SP, Kocemba KA, de Lau W, Kersten MJ, de Bruin AM, Guikema JE, Clevers H, Spaargaren M, Pals ST.

Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):376-381. doi: 10.1073/pnas.1618650114. Epub 2016 Dec 27.

10.

Challenging perspectives on the cellular origins of lymphoma.

Malcolm TI, Hodson DJ, Macintyre EA, Turner SD.

Open Biol. 2016 Sep;6(9). pii: 160232.

11.

SNPs Array Karyotyping in Non-Hodgkin Lymphoma.

Etebari M, Navari M, Piccaluga PP.

Microarrays (Basel). 2015 Nov 12;4(4):551-69. doi: 10.3390/microarrays4040551. Review.

12.

Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.

Peng C, Zhao H, Chen W, Song Y, Wang X, Li J, Qiao Y, Wu D, Ma S, Wang X, Gao C.

Oncotarget. 2016 Oct 11;7(41):66822-66834. doi: 10.18632/oncotarget.11651.

13.

Impact of intracellular ion channels on cancer development and progression.

Peruzzo R, Biasutto L, Szabò I, Leanza L.

Eur Biophys J. 2016 Oct;45(7):685-707. Epub 2016 Jun 11. Review.

14.

The curious origins of angioimmunoblastic T-cell lymphoma.

Cortés JR, Palomero T.

Curr Opin Hematol. 2016 Jul;23(4):434-43. doi: 10.1097/MOH.0000000000000261.

15.

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value.

Viziteu E, Kassambara A, Pasero P, Klein B, Moreaux J.

Biomark Res. 2016 Feb 13;4:3. doi: 10.1186/s40364-016-0057-4. eCollection 2016.

16.

Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion.

Chen NP, Uddin B, Voit R, Schiebel E.

Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):990-5. doi: 10.1073/pnas.1515605113. Epub 2016 Jan 8.

17.

The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer.

Siprashvili Z, Webster DE, Johnston D, Shenoy RM, Ungewickell AJ, Bhaduri A, Flockhart R, Zarnegar BJ, Che Y, Meschi F, Puglisi JD, Khavari PA.

Nat Genet. 2016 Jan;48(1):53-8. doi: 10.1038/ng.3452. Epub 2015 Nov 23.

18.

Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas.

Herek TA, Shew TD, Spurgin HN, Cutucache CE.

PLoS One. 2015 Nov 13;10(11):e0142682. doi: 10.1371/journal.pone.0142682. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0146673.

19.

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.

Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F, Bellan C, Rossi M, Sapienza MR, Laginestra MA, Etebari M, Rogena EA, Tumwine L, Tripodo C, Gibellini D, Consiglio J, Croce CM, Pileri SA, Leoncini L.

Oncotarget. 2016 Jan 5;7(1):224-40. doi: 10.18632/oncotarget.4399.

20.

IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation.

Piccaluga PP, Agostinelli C, Fuligni F, Righi S, Tripodo C, Re MC, Clò A, Miserocchi A, Morini S, Gariglio M, Ferri GG, Rinaldi-Ceroni A, Piccin O, De Andrea M, Pileri SA, Landolfo S, Gibellini D.

J Immunol Res. 2015;2015:747645. doi: 10.1155/2015/747645. Epub 2015 Jun 22.

Supplemental Content

Support Center